Add Company
Join Now

HealthiVibe Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • HealthiVibe's estimated annual revenue is currently $9.4M per year.(i)
  • HealthiVibe's estimated revenue per employee is $201,000

Employee Data

  • HealthiVibe has 47 Employees.(i)
  • HealthiVibe grew their employee count by -39% last year.

HealthiVibe's People

NameTitleEmail/Phone
1
Senior Director, Patient Insights ResearchReveal Email/Phone
2
Senior Director, Patient Centric SolutionsReveal Email/Phone
3
Director OperationsReveal Email/Phone
4
IT Project ManagerReveal Email/Phone
5
Manager, Client SolutionsReveal Email/Phone
6
PM, Medical Communications OversightReveal Email/Phone
7
Research Specialist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16.7M8326%$210MN/A
#2
$30.2M220N/AN/AN/A
#3
$7.2M369%N/AN/A
#4
$9.4M47-39%N/AN/A
#5
$4.8M240%N/AN/A
#6
$13.9M6911%N/AN/A
#7
$18.7M9343%$91.5MN/A
#8
$26.9M13422%N/AN/A
#9
$13.9M6919%N/AN/A
#10
$5.8M290%N/AN/A
Add Company

What Is HealthiVibe?

HealthiVibe offers a systematic, evidence-based process for companies to engage the patient at every stage of the pharmaceutical project lifecycle: from clinical trial design through post-approval activities and research. We offer full-service patient initiatives, with a focus on patient insights and communication, to help biopharmaceutical companies create more patient-centered programs.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

-39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HealthiVibe News

2022-03-22 - How Janssen/HealthiVibe's Program Found The Right ...

How Janssen/HealthiVibe's Program Found The Right Messages To Improve Trial Diversity. 10 Mar 2022. Analysis. Alaric DeArment biotechvisigoth...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M4718%N/A
#2
$7.7M472%N/A
#3
$6.8M470%N/A
#4
$3.5M4712%N/A
#5
$15M47-31%N/A